Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Thyroid : Official Journal of the American Thyroid Association|March 21, 2013
The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutationsMarika A Russo, Kristy S Kang, Antonio Di Cristofano
Frontiers in Endocrinology|June 2, 2012
Mouse models of follicular and papillary thyroid cancer progressionMarika A Russo, Valeria G Antico Arciuch, Antonio Di Cristofano
Mini Reviews in Medicinal Chemistry|November 26, 2009
Small molecule integrin antagonists in cancer therapyMayra Paolillo, Marika A Russo, Massimo Serra, et al.
Pharmacological Research|November 26, 2009
Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cellsMayra Paolillo, Marika A Russo, Daniela Curti, et al.
Cancer Research|June 26, 2013
Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cellsValeria G Antico Arciuch, Marika A Russo, Kristy S Kang, et al.
Endocrine-Related Cancer|July 12, 2014
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpressionDevora Champa, Marika A Russo, Xiao-Hui Liao, et al.
Journal of Biomedicine & Biotechnology|August 7, 2009
Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimensSergio Comincini, Mayra Paolillo, Giulia Barbieri, et al.
International Journal of Oncology|November 24, 2012
A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cellsMarika A Russo, Mayra Paolillo, Yuly Sanchez-Hernandez, et al.
Oncotarget|December 23, 2011
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumorsValeria G Antico Arciuch, Marika A Russo, Mariavittoria Dima, et al.
Pageof 1